emailthe administrators, page-22

hc - that's the most important question isn't it....was the device infact 'any good'. well yes according to the co. announcements re. trial results, it was very effective and satisfied the required endpoints with no more adverse events than other comparable devices. Thoratec devices I believe delivered less impressive results. So the thing that investors need to do as a group before deciding to put more money in - is to get an independent opinion from a few clinicians who work in that area. There is a potental to be led down the garden path again by 'managers' who see an opportunity to squeeze a bit more out of the old girl yet.